EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
10 10-2021

EBC raises awareness on World Mental Health Day


EBC is happy to support and recognise World Mental Health Day, which takes place annually on 10 October. The overall objective of World Mental Health Day is to raise awareness of mental health issues around the world and to mobilise efforts in support of mental health. This year's theme is ‘Mental Health in an Unequal [...]

28 06-2021

VOT2 Case Studies on Rare Diseases & Mental Disorders present findings at Synthesis Meeting on 8 June 2021


On 8 June 2021, EBC hosted a virtual Synthesis Meeting for the Value of Treatment 2 case study working groups to present their preliminary findings. The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project coordinated by the European Brain Council (EBC). EBC conceptualized in 2015 the Value [...]

28 06-2021

EBC raises awareness on International Phenylketonuria Day


EBC is happy to recognise and support International Phenylketonuria (PKU) Day, which takes place annually on 28 June — the birthday of two stalwarts of PKU, Robert Guthrie (1916-1995) and Horst Bickel (1918-2000). The ongoing 2019-2021 Value of Treatment (VOT) project for Brain Disorders and its recent synthesis meeting on 8 June 2021 aimed to [...]

27 05-2021

EBC launches “RETHINKING MS in times of COVID-19” on the occasion of World Multiple Sclerosis Day


On the occasion of the approaching World Multiple Sclerosis Day (30 May 2021), the European Brain Council is excited to announce the release of its new policy paper, "RETHINKING MS in times of COVID-19". This new paper is part of the main report "RETHINKING MS in Europe", a research-driven project offering tangible policy changes [...]

19 05-2021

IMI PARADIGM develops toolkit to make patient engagement in medicines development easier for all


There is consensus among stakeholders that patient engagement at different points of the medicines lifecycle is critical to fostering patient access to innovative therapeutic solutions, and delivering better health outcomes for patients.  IMI PARADIGM, a public private consortium consisting of patients, academia, industry, HTA bodies and regulators, developed a toolkit to make patient engagement [...]

17 05-2021

Registration for the Value of Treatment 2 Synthesis Meeting open!


The European Brain Council is pleased to invite you to join us for the upcoming Value of Treatment for Brain Disorders Research Project “Case studies on Rare Diseases and Mental Disorders” Virtual Synthesis Meeting to be held on 8 June 2021 at 13:00-17:30. The Value of Treatment (VOT) is a health economics and outcomes research project addressing all brain disorders, conceptualized in 2015 by the [...]

31 03-2021

Save the Date for the 3rd Brain Innovation Days on 27 April 2021 – Fast-tracking brain innovation in times of COVID-19


The 3rd Brain Innovation Days digital event on "Fast-tracking brain innovation in times of COVID-19" will take place on 27 March 2021 (12:30 - 14:00 CET) The last 14 months have been a most testing time for the world in general and for global health in particular. COVID-19 took the world by surprise as [...]

18 03-2021

Save the Date for the Value of Treatment 2 Synthesis Meeting on 8 June 2021


The European Brain Council (EBC) is pleased to launch the Save the Date for the Value of Treatment 2 (VOT 2) Synthesis Meeting, to be held virtually on 8 June 2021 (13:00-17:00 CET). Experts participating in the research will present a synthesis of the results so far and examine the most critical issues in brain diseases in Europe [...]

16 12-2020

Value of Treatment 2: working sessions report


The Value of Treatment (VOT) research project, initiated and coordinated by EBC, aims to identify treatment gaps and causing factors along the care pathway and propose solutions to address them; assess health gains and socio-economic impacts resulting from best practice healthcare interventions, in comparison with current care or no treatment. Furthermore, its objective is to [...]

Go to Top